Yposkesi, an SK pharmteco company Employee Directory
Biotechnology ResearchÎle-de-France, France51-200 Employees
Yposkesi, an SK pharmteco company, operates as a contract development and manufacturing organization focused on gene therapy viral vectors. Its expertise spans lentiviral vectors and AAV, with cGMP manufacturing capabilities geared toward supporting biotech and pharmaceutical partners through late-stage clinical development and toward commercialization of advanced therapy medicinal products. The facility includes multiple manufacturing suites for bulk drug substances up to 1,000 liters and fill‑finish operations, and is located on the Genopole Campus in Corbeil-Essonnes, Île-de-France (south of Paris). As a mid-sized firm within the biotechnology research sector, Yposkesi is positioned among Europe’s larger CDMOs for viral vector production. Recent developments include the launch of LentiSure in April 2023 and AAVelocity in November 2023, signaling ongoing platform-focused innovation in gene therapy vector manufacturing. The company is planning a capacity expansion to about 100,000 square feet with a second large-scale facility designed for EMA and FDA compliance, broadening its ability to support late-stage programs for ATMPs.
1-888-653-2347 
support@leadiq.com 
